Healthcare procurement is becoming more complex as providers manage rising costs, tighter operating budgets and increasingly sophisticated products and services. In the US, hospital expenses increased 7.5% in 2025, while spending on supplies increased 9.9% and drug spending rose 13.6%.
As a result, purchasing decisions increasingly consider the economics of the product over its useful life, rather than the initial purchase price alone. Clinical performance, maintenance, supply continuity, interoperability and implementation requirements can all influence the eventual cost and value of a procurement decision.
Price Remains Important, But It Is No Longer the Entire Evaluation
Competitive tendering remains an important procurement mechanism, particularly for standardized products and high-volume categories. However, the lowest quoted price does not necessarily represent the lowest cost for a healthcare organization.
Total cost of ownership can include:
- Purchase and installation
- Maintenance and servicing
- Training
- Consumables
- Integration with existing systems
- Replacement requirements
- Inventory and supply costs
The relative importance of these factors varies by category.
A commodity consumable may be highly price-sensitive, whereas a connected medical device can involve substantial implementation and integration considerations.
Competing solely on price can be difficult when the buyer’s evaluation includes the broader financial and operational implications of the purchase.
Procurement Decisions Involve Multiple Stakeholders
The purchasing function is generally only one part of the decision-making process.
Clinical teams may evaluate product performance and usability.
Finance teams assess budget impact and financial justification.
Supply-chain teams consider availability and logistics, while IT and information-security teams may become involved when products require connectivity or integration.
Many hospitals also use value-analysis committees to assess products before they are approved for procurement. The composition and criteria of these committees vary by organization and product category.
Understanding this decision structure can help suppliers determine:
- Who initiates the purchase
- Who evaluates the product
- Who controls the budget
- Who can delay approval
- Which criteria determine final selection
This stakeholder analysis is particularly important for suppliers entering new markets, where procurement practices may differ substantially between public and private healthcare systems.
Category Economics Determine What Buyers Prioritize
Healthcare procurement does not operate according to a single purchasing model.
What buyers value depends on the category:
- Medical devices: Clinical reliability, physician preference, and ongoing support.
- Pharmaceuticals: Unit cost, reimbursement status, and regulatory compliance.
- Software: Interoperability, data governance, and cybersecurity.
A procurement assessment should establish the decision criteria specific to the product category and buyer segment.
This can also reveal opportunities for suppliers to differentiate on areas other than price, such as service coverage, product availability, implementation support or demonstrated economic value.
The Tender Is Only One Part of the Procurement Cycle
Important procurement decisions are often made before suppliers submit their bids.
Healthcare organizations may first establish technical specifications, assess available suppliers, determine purchasing volumes and decide whether requirements can be standardized across facilities.
Larger purchasing groups also aggregate demand to strengthen their negotiating position.
Nexdigm’s research identifies centralized purchasing, joint procurement and demand aggregation among approaches used by healthcare systems to improve purchasing efficiency, particularly for medicines and medical devices.
These upstream decisions can affect the size of the addressable contract and the competitive condition before the tender is released. Understanding the procurement cycle therefore requires looking beyond published tenders to how demand is organized and purchasing requirements are established.
Supplier Selection Reflects Operational Risk
- Patient impact over price: Low-cost bids carry hidden risks if suppliers lack production scale or reliable logistics.
- Key qualification criteria: Selection hinges on supply continuity, regulatory compliance, and surge capacity.
Procurement must evaluate commercial attractiveness and supplier reliability in tandem.
Turning Procurement Intelligence into Commercial Priorities
Nexdigm’s healthcare procurement market assessment helps medical-technology companies, pharmaceutical businesses and healthcare service providers understand the purchasing environment before allocating resources to market development or tender participation.
The assessment can examine:
- Buyer landscape: Institutional buyers, procurement groups and purchasing structures
- Decision criteria: Clinical, financial, operational and technical requirements
- Competitive positioning: Suppliers, pricing, product specifications and service models
- Contract potential: Procurement volumes, tender activity and purchasing cycles
- Market access: Qualification, regulatory and contracting requirements
This analysis helps companies identify the buyer segments with the strongest commercial potential and understand the requirements that need to be addressed to compete effectively.
What Nexdigm Examines Before Market Entry or Tender Participation
Nexdigm structures the assessment across five areas:
- 01 | Procurement Landscape
Map major buyers, procurement channels, purchasing structures and category-level demand. - 02 | Buyer Decision-Making
Assess the stakeholders involved in supplier selection and the criteria used to evaluate competing products or services. - 03 | Competitive Benchmarking
Evaluate suppliers, pricing structures, product positioning, service offerings and existing contracts. - 04 | Opportunity and Risk
Assess tender pipelines, purchasing volumes, market-access requirements, qualification barriers and execution risks. - 05 | Commercial Prioritization
Rank buyer groups and procurement opportunities according to contract potential, competitive intensity, accessibility and expected commercial value.
The framework provides a basis for determining which accounts to pursue, how the offering should be positioned and where market-development resources are most likely to generate returns.
From Procurement Complexity to a More Focused Market Strategy
A medical-technology supplier assessed 35 institutional buyers across 3 markets before expanding its sales operations. Nexdigm evaluated procurement structures, decision criteria, competitor positioning and contract potential, identifying 10 priority accounts and the pricing, product and engagement considerations relevant to each buyer group.
Nexdigm’s procurement assessment decodes buyer economics,
helping suppliers target high-value accounts, outmanoeuvre competitors, and focus market entry.
To take the next step, simply visit our Request a Consultation page and share your requirements with us.
Harsh Mittal
+91-8422857704
[email protected]